FDA and EMA guidance now call for endpoints that capture the full picture of patient well-being, including physical, psychological, and social. If your obesity trials aren't incorporating this multidimensional approach, ...
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.
We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
Quality
We are committed to exceeding expected quality standards demanded by our clients, patients and regulatory authorities.
ICON at a glance
ICON is delivering successful outcomes across the clinical development lifecycle.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
ICON Cares program
Expresses our passion and achievements around environmental, social and governance (ESG) efforts.
